Stoke Therapeutics (STOK) Other Working Capital Changes (2018 - 2026)

Stoke Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 191.71% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 108.66% increase from a year earlier, with the FY2025 full-year figure at -$130000.0, up 99.56% from the prior year.
• Other Working Capital Changes declined to $3.6 million in Q1 2026 per STOK's latest filing, from $4.5 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $52.6 million in Q2 2022 and bottomed at -$52.2 million in Q3 2022.
• The 5-year median for Other Working Capital Changes is $514000.0 (2023), against an average of $1.3 million.
• Biggest YoY gain for Other Working Capital Changes was 6080.08% in 2022; the steepest drop was 22789.91% in 2022.
• Year by year, Other Working Capital Changes stood at $48.1 million in 2022, then plunged by 108.68% to -$4.2 million in 2023, then tumbled by 400.89% to -$20.9 million in 2024, then jumped by 121.71% to $4.5 million in 2025, then slipped by 20.99% to $3.6 million in 2026.
• Per Business Quant, the three latest STOK Other Working Capital Changes figures stand at $3.6 million (Q1 2026), $4.5 million (Q4 2025), and -$4.1 million (Q3 2025).